References
- Husby G, Marhaug G, Dowton B, Sletten K, Sipe J D. Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid: Int J Exp Clin Invest 1994; 1: 119–137
- Betts J C, Edbrooke M R, Thakker R V, Woo P. The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatoma cells. Scand J Immunol 1991; 34: 471–482
- Sipe JD and Committee. Revised nomenclature for serum amyloid A. Amyloid: Int J Exp Clin Invest 1999; 6: 67–70
- Dwulet F E, Benson M D. Amino acid structures of multiple forms of amyloid related serum protein SAA from a single individual. Biochemistry 1988; 27: 1677–1682
- Strachan A F, de Beer F C, van der Westhuyzen D R, Coetzee G A. Identification of three isoform patterns of human serum amyloid A protein. Biochem J 1988; 250: 203–207
- Liepnieks J J, Kluve-Beckerman Band Benson M D. Characterization of amyloid A protein in human secondary amyloidosis. The predominant deposition of serum amyloid A1. Biochim Biophys Acta 1995; 1270: 81–86
- Baba S, Masago S A, Takahashi T, Kasama T, Sugimura H, Tsugane S, Tsutsui Y, ShirasawaH. A novel alleic variant of serum amyloid A. SAAlg: Genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic amyloidosis. Hum Mol Gener 1995; 4: 1083–1087
- Yamada T, Itoh Y, Itoh K. Analysis of serum amyloid Al alleles by PCR-RFLP. Rinsho Byori (English abstract) 1999; 47: 53–55
- Faulkes D, Betts J, Woo P. Alleles of human SAA1. Amyloid and Amyloidasis, R Kisilevsky, M D Benson, B Frangione, J Gauldie, T J Muckle, I D Young. Parthenon Publishing, New York 1993; 73–74
- Yamada T, Uchiyama K, Yakata M, Gejyo F. Sandwich enzyme immunoassay for serum amyloid A protein (SAA). Clin ChimActa 1989; 178: 167–176
- Yamada T, Okuda Y, Itoh Y. The frequency of serum amyloid A2 alleles in the Japanese population. Amyloid: Int J Exp Clin Invest 1998; 5: 208–211
- Yamada T, Nomata Y, Sugita O, Okada M. A rapid method for measuring serum amyloid A protein by latex agglutination nephelometric immunoassay. Ann Clin Biochem 1993; 30: 72–76
- Kluve-Beckerman B, Yamada T, Hardwick J, Liepnieks J J, Benson M D. Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2. Biochem J 1997; 322: 663–669
- Benson M D, Kluve-Beckerman B, Liepnieks J J, Murrell J R, Hanes D, Uemichi T. Metabolism of amyloid proteins. Ciba Found Symp 1996; 199: 104–118
- Skinner M, Connors L H, Rubinow A, Libbey C, Sipe J D, Cohen A S. Lowered prealbumin levels in patients with familial myloid polyneuropathy VAP) and their non-afTected but at risk relatives. Am J Med Sci 1985; 289: 17–21
- Booth D R, Booth S E, Gillmore J D, Hawkins P N, Pepys M B. SAA1 alleles as risk factors in reactive systemic amyloidosis. Amyloid: Int J Exp Clin Invest 1998; 5: 262–265